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In the early post-stroke period elevation of both body temperature and blood glucose is 
associated with significantly worse stroke outcomes (Azzimondi et al., 1995; Greer, Funk, 
Reaven, Ouzounelli, & Uman, 2008; Pulsinelli, Levy, Sigsbee, Scherer, & Plum, 1983; 
Wang, Lim, Levi, Heller, & Fisher, 2000; Weir, Murray, Dyker, & Lees, 1997).  In the first 
days of an acute stroke, elevation of temperature above 37.5ºC occurs in one fifth to almost 
one half of patients(Castillo, Davalos, Marrugat, & Noya, 1998) and the detrimental effects 
of fever following stroke are attributed to increased cerebral metabolic demands (Ginsberg & 
Busto, 1998), changes in the blood-brain barrier permeability, acidosis and an increased 
release of excitatory amino acids (Busto et al., 1989) which causes infarct expansion (Boysen 
& Christensen, 2001).  There also is a significant association between post-stroke 
hyperglycaemia and poor recovery (Williams et al., 2002).  Up to 68% of all patients 
experience hyperglycaemia with the first 24 hours of their acute stroke. (Allport et al., 2006; 
Scott et al., 1999)  Hyperglycaemia following stroke has been shown to increase infarct size 
(Allport, Baird, & Davis, 2008; Pulsinelli et al., 1983) and lead to poorer outcomes 
independent of the patient’s pre-stroke history of diabetes.(Pulsinelli et al., 1983; Weir et al., 
1997)  The incidence of dysphagia in the acute post stroke period ranges from 37% to 78% 
(Martino et al., 2005) and stroke patients with dysphagia are three times more likely to 
develop pneumonia than those without dysphagia (Doggett et al., 2001; Martino et al., 2005).  
Thus, optimal management of these three common physiological disturbances, namely, fever, 
hyperglycaemia and dysphagia are important elements of organised stroke care with potential 
to significantly influence outcomes.  All three have been identified in international 
guidelines, as priority care issues for inpatient stroke management (Adams et al., 2007; 
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European Stroke Organisation (ESO) Executive Committee & ESO Writing Committee, 
2008; National Institute for Health and Clinical Excellence, 2008; National Stroke 
Foundation, 2007, 2010). 
 
Changing clinician practice remains a challenge (Morris, Wooding, & Grant, 2011) 
Successful translation of evidence into practice requires redress of barriers that generally 
might include disagreement among experts about best practice, attractiveness of alternative 
practices, inapplicability of guidelines to certain patient subgroups, institutional inertia, 
vested interests and ineffective continuing education (Grimshaw, Eccles, & Tetroe, 2004; 
Grol & Grimshaw, 2003).  Production of up-to-date evidence-based clinical guidelines 
without targeted implementation strategies does not ensure practice change (Grimshaw J. M. 
et al., 2004).  The need to identify and overcome barriers during implementation is well 
accepted (Grol et al., 2003).   
 
In an effort to improve management of fever, hyperglycaemia and swallowing following 
stroke, the Quality in Acute Stroke Care (QASC), a cluster randomised control trial, 
evaluated the effectiveness of implementation of evidence-based clinical treatment protocols 
for the management of fever, glucose (sugar) and swallowing difficulties (the Fever, Sugar, 
Swallow [FeSS] protocols) to improve 90-day patient outcomes.  In brief, the protocols 
consisted of: monitoring and treatment of temperatures > 37.5ºC; treatment of major 
hyperglycaemia (fingerprick blood glucose levels > 11 mmol/L for diabetics and >16 mmol/L 
for non-diabetics) with saline initially and/ or insulin; and the training of nurses to undertake 
swallowing screening using the ASSIST screening tool (Managers of Great Metropolitan 
Speech Pathology Services in NSW Health, 2004) with referral to a speech pathologist for 
full swallowing assessment only when patients failed the screen.  Evidence-based strategies 
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used to facilitate implementation were; multidisciplinary team building workshops 
(Hamilton, McLaren, & Mulhall, 2007) to identify barriers and enablers (Grol, Wensing, & 
Eccles, 2005); identification of a clinical site champion (Flodgren et al., 2011); use of a 
standardised interactive education program (Forsetlund et al., 2009), (O'Brien et al., 2007); 
and use of reminders (Grimshaw J. M. et al., 2004).  Following the workshops, sites were 
asked to address these barriers and self-nominate a date for commencing use of the FeSS 
protocols once barriers had been addressed.  Nineteen acute stroke units in New South Wales 
(NSW) Australia participated, providing data from 1696 patients.  Our results showed that 
patients cared for in stroke units who received implementation support were 15.7% more 
likely to be alive and independent 90-days following their stroke.  They also had fewer 
episodes of fever, lower mean temperatures, lower mean blood glucose levels, and improved 
screening for swallowing difficulties (Middleton et al., 2009; Middleton et al., 2011). 
 
In this paper, we report the perceived barriers and enablers identified by clinicians prior to 
implementation of the FeSS protocols.  At the conclusion of the trial, we revisited these 
perceived pre-trial barriers to determine which, if any, were actual barriers as reported by the 
clinical site champions who also were our local trial contacts at our intervention sites.  This 
information may be useful for clinicians seeking to implement similar protocols. 
 
METHOD 
A mixed method design was used comprising a qualitative phase using workshops to identify 
perceived barriers and enablers prior to implementation of the FeSS protocols, and a 
quantitative approach post-implementation using an on-line survey to elicit actual barriers 




Pre-implementation identification of perceived barriers and enablers to Fess protocol 
uptake 
Two interactive multidisciplinary workshops were conducted at each of the ten intervention 
stroke units.  At both workshops, following presentations to clinicians regarding the QASC 
trial and the clinical protocols, the clinicians were asked two questions as follows:  what are 
the perceived barriers and enablers to use of these protocols:  i) within the stroke unit; and ii) 
at the hospital (organisational) level.  Senior clinicians within the stroke team were invited to 
attend the first workshop, namely, the medical director, nurse unit manager, stroke unit co-
ordinator, director of speech pathology.  The second workshop was held with a convenience 
sample of multidisciplinary bedside clinicians and both were held at a time convenient to all. 
These workshops were conducted by SM, CL and SD, two to four weeks apart and 
approximately six weeks prior to implementation of the FeSS protocols.   
 
Post-implementation actual barriers and enablers to Fess protocol uptake 
An on-line survey was sent to the clinical site champion at each of the 10 QASC intervention 
stroke units in June 2011, six months post completion of the main QASC trial.  Our survey 
included questions about respondent demographics (four questions) and specific questions 
derived directly from perceived barriers identified by clinicians at the QASC Trial pre-
implementation workshops.  These were grouped as follows: policy barriers (five questions), 
workforce barriers (six questions), equipment barriers (four questions) and education barriers 
(five questions).  Next, participants were asked to list any additional actual barriers not 
previously identified (one question).  Each survey item was rated on a five-point Likert scale 




In addition, clinical site champions were asked whether they were still using each of the FeSS 
protocols (‘Yes’, ‘No’, ‘Don’t know/ Can’t remember’) and if they would recommend the 
FeSS protocols to other stroke units (‘highly likely’ to ‘highly unlikely’) whether the FeSS 
protocols empowered nursing staff to approach the multidisciplinary team about patient 
management (‘strongly agree’ to ‘strongly disagree’); and if they would recommend the FeSS 
protocols for use in emergency departments (‘Yes’, ‘No’, ‘Don’t know/ Can’t remember’).  
Respondents were also able to provide comments in this section. 
 
Data Analysis 
Participants responses from the pre-implementation workshops were transcribed into lists 
following the workshops and then were coded according to barriers, enablers and strategies to 
overcome barriers by one of the researchers.   The coding frame was developed iteratively as 
two researchers reviewed the feedback.  We undertook a content analysis grouping barriers, 
both at the stroke unit level and the organisational level into relevant categories. Responses 
from the two workshops at each site were grouped together.  Recurrent factors were noted 
and feedback excerpts were allocated to these codes. In addition, differences in the feedback 
between the sites were noted.  Participant quotes were used to illustrate meaning in the main 
factors derived.  
 
Frequencies from the post-implementation survey were determined. Each of the perceived 
barriers was defined as being an ‘actual barrier’ where greater than or equal to 50% of 
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Pre-Implementation: Perceived Barriers  
A total of 20 pre-implementation workshops were conducted (two at each of the 10 
intervention stroke units).  The number of participants per site ranged from 4 to 13 and the 
majority of the 111 clinicians that attended the workshops were nurses (n=70, 63%) (Table 
1).  Pre-implementation perceived barriers were centred on four categories: policy, 
workforce, equipment and education as outlined below (Table 2).  The majority of barriers 
were uniform between sites with the equipment barriers differing in which equipement issues 
were barriers at each site.  
 
Policy related barriers 
There were three policy barriers related to the implementation of the FeSS protocols. The 
need for written orders from doctors for nurses to commence saline and/ or insulin according 
to the hyperglycaemic protocol was identified as a barrier, as was no previous use of insulin 
infusions. 
‘the doctors won’t want to come up in the middle of the night to write up insulin’  
 
In addition, the requirement for nurses to obtain a written order for all but the first dose of 
paracetamol was also considered a likely barrier (Table 2).  In all NSW hospitals, nursing 
staff were permitted by NSW Department of Health protocol to administer only the first dose 




Workforce related barriers 
There were eight barriers identified related to workforce issues.  Patient safety, largely 
associated with management of insulin infusions, was perceived to be a potential barrier.  
 
‘what happens when we have more than one patient with an insulin infusion, how can 
we maintain patient safety’ 
 
Finding a member of staff to re-cannulate patients after hours was identified as a possible 
workforce barrier, as was the shortage of speech pathologists to train nurses to perform and 
access swallow screens (Table 2).  Increased workload was a concern with particular 
reference to the possible need for hourly blood glucose monitoring for glycaemically unstable 
patients.  There was also concern that there could be a resulting insufficient number of staff 
to safely look after more than one patient requiring an insulin infusion.  Patients with insulin 
infusions require a nurse escort should they need to leave the stroke unit for any tests (e.g. 
imaging) and this then could leave the stroke unit short staffed.  Endorsed enrolled nurses’ 
(enrolled nurses in Australia obtain a one year diploma of enrolled nursing from a Technical 
And Further Education College; endorsed enrolled nurses can also administer some 
medications) inability to administer insulin was identified as a factor potentially increasing 
the workload of the registered nurse.  
 
In addition, on some stroke units where use of casual nursing staff occurred, the transient 
nature of their employment was seen as possibly increasing the work load of the regular 
stroke unit nurses as casual nursing staff may not have undergone any local education or 




Equipment related barriers 
Equipment barriers were identified with concerns about lack of thermometers, blood glucose 
monitors, fluid pumps, and syringe drivers on the stroke units (Table 2). 
 ‘what if we are unable to get a fluid pump from the hospital supply’ 
 
Education related barriers 
Seven barriers were identified relating to education.  The logistics of training all the clinical 
staff including those who worked only weekend shifts and night duty was highlighted.  Since 
our swallowing management protocol consisted of nurses being trained to undertake 
swallowing screening (previously the remit solely of speech pathologists) clinicians were 
concerned that this would result in reluctance of nursing staff to undertake the screening role 
and training required to use the Acute Screening of swallow in Stroke / TIA (ASSIST) tool 
(Table 2).  Some concern also was expressed about the possibility of poor levels of 
engagement with both doctors and speech pathologists associated with the changed work 
practices.   
 The speechies won’t be happy we are taking over their jobs!’ 
The issue of medical staff not being aware of the trial was also raised.  Other barriers specific 
to swallow management included concern about the time needed to undergo swallow screen 
education and reluctance on behalf of the medical teams to use the ASSIST tool (Table 2). 
 
Pre-Implementation: Enablers 
Enablers identified during the workshops fell into the two main categories of organisational 
support and integration of the FeSS protocols into routine care.  Enablers’ related to 
organisational support included the concept of having champions for the trial, having the 
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support of the other neurologists (in addition to Stroke Unit Director) and having the support 
of the senior staff (e.g. Director of Allied Health).   
 
Enablers related to integration of the FeSS protocols into care were: nurses’ ability to adapt 
their own local care plans and policies to reflect the FeSS protocols; being able to augment 
implementation with the use of local strategies (i.e. laminating the protocols and placing them 
at the bedside as suggested by one site); and having staff that were always allocated to the 
stroke unit (Box 2). 
 
Post-Implementation: Actual Barriers 
All clinical site champions from our ten intervention stroke units participated in our online 
post-implementation survey (100% response rate), the majority of whom were clinical 
nursing consultants (n=7, 70%) (Table 1).  All also had attended the pre-implementation 
workshops.  Only five of the 22 perceived barriers identified pre-implementation were listed 
as actual barriers and are outlined below using the same categories from the pre-
implementation survey (Table 2). 
 
Policy related barriers  
In relation to hospital policy, only two of the perceived barriers: no previous use of insulin 
infusions (n=6, 60% ‘agreed’ or ‘strongly agreed’); and requiring written orders for the 
insulin infusions (n=5%, 50% ‘agreed’ or ‘strongly agreed’) were considered to be actual 
barriers post-implementation.  Participants no longer considered the requirement for written 
orders for paracetamol beyond the first dose to be an actual barrier (n=3, 30% ‘agreed’ or 




Workforce related barriers 
There were no workforce related pre-implementation barriers that were found to be actual 
post-implementation barriers. Only 10% (n=1) of participants ‘agreed’ or ‘strongly agreed’ 
that increased workload had been an actual barrier.  The issue of high numbers of casual staff 
working on the stroke unit was not considered an actual barrier (n=2, 20% ‘agreed’ or 
‘strongly agreed’).  Examination of workforce barriers showed that less than half of the 
participants considered finding staff to re-cannulate patients after hours as a barrier (n=4, 
40%. agreed’ or ‘strongly agreed’) and only 20% (n=2) ‘agreed’ or ‘strongly agreed’ that not 
enough nurses to carry out hourly observations was a barrier.  When looking specifically at 
workforce barriers related to the swallow protocol, only one person (n=1, 10%) ‘agreed’ or 
‘strongly agreed’ insufficient numbers of speech pathologists to carry out the education was 
an actual barrier. With regard to the sugar protocol, 10% (n=1) ‘agreed’ or ‘strongly agreed’ 
that insufficient staff to safely look after more than one patient on an insulin infusion was a 
barrier. 
 
Equipment related barriers 
Lack of equipment was not considered to be an actual barrier by participants. Specifically, 
10% (n=1) ‘agreed’ or ‘strongly agreed’ lack of thermometers was an actual barrier; 30% 
(n=3) ‘agreed’ or ‘strongly agreed’ lack of syringe drivers was an actual barrier’ (Table 2). 
 
Education related barriers 
Three educational barriers identified pre-implementation that were found to be actual barriers 
post-implementation. Medical staff not being aware of the trial and related protocols (n=5, 
50% ‘agreed’ or ‘strongly agreed’); poor level of engagement of the medical staff (n=5, 50% 
‘agreed’ or ‘strongly agreed’); and medical staff reluctance to use the ASSIST tool (n=8, 80% 
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‘agreed’ or ‘strongly agreed’) were considered to be actual barriers (Table 2). Less than half 
of participants (n=4, 40%) ‘agreed’ or ‘strongly agreed’ that the time needed by nurses to 
undergo training and competency assessment by speech pathologists was an actual barrier.  
Poor levels of engagement by speech pathology staff was not considered to have been an 
actual barrier (n=0, 0% ‘agreed’ or ‘strongly agreed’) (Table 2).   
 
On-going use of FeSS protocols 
Over three quarters of participants (n=7) were currently using the FeSS protocols on their 
unit, with all respondents currently using the swallowing element of the FeSS protocol (n=10, 
100%).  In addition, 90% of participants (n=9) recommended that the FeSS protocols be used 
in the emergency department, and would be ‘highly likely’ or ‘likely’ to recommend the 
FeSS protocols to other stroke units.  Over half of all participants ‘strongly agree’ or ‘agree’ 
that the three elements (fever: n=6, 60%; sugar: n=7, 70%; swallowing: n=9, 90%) of the 
FeSS protocols empowered nursing staff to approach the multi-disciplinary team regarding 
patients management (Table 3).  Overall, open-ended responses gathered from the 
participants indicated underlying challenges with medical teams in engaging with the 
adoption and use of the FeSS protocols at the local level: 
 
“The challenge was with rotating medical staff who were not aware or did not want 
to become aware of the protocols” 
 
Participants also identified that initial uptake of the FeSS protocols required ongoing support, 




“Implementation of the protocols required strong leadership and constant monitoring 
to ensure the processes became daily business” 
 




This paper outlines results of our barrier assessment prior to and following pre-planned 
implementation of new evidence-based clinical protocols for acute stroke management.  
Barrier assessment has been shown to be a crucial step in successful implementation of 
evidence to practice (Grol et al., 2003; Hamilton et al., 2007; Scott et al., 2009).  Our 
approach is novel, in that, at the end of the trial, we re-examined the perceived barriers 
identified pre-implementation to determine which, if any, had been actual barriers to protocol 
uptake.  This study was limited by the small sample size in the post-implementation survey 
which included only clinical site champions .  However the role of the clinical site champion 
was instrumental to the implementation of the FeSS protocols and we believe their ongoing 
engagement with the study at all stages gives a valid and reliable representation of key 
barriers and enablers.  The QASC trial pre-implementation perceived barriers and actual 
barriers fell into four main categories; policy, workforce, education and equipment.   
 
While all of three protocols required new ways of working within the intervention stroke 
units, it was the fever and sugar protocols that were identified pre-intervention as potential to 
experience barriers from a policy perspective.  Indeed, in relation to the sugar protocol, the 
use of insulin infusions as a new procedure was found post-intervention to have been an 
actual barrier to implementation.  In relation to the fever protocol, it is important to note that 
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in the QASC trial settings, nurses from all intervention units were permitted by a Department 
of Health policy to administer the first dose of oral paracetamol for fever without a pre-
signed written medical order and, hence, rapid administration of an initial paracetamol dose 
by a nurse for fever was not perceived as a pre-intervention barrier in our setting.  However, 
this may be a barrier in other jurisdictions or hospitals where such practices may not be 
policy.  Second and subsequent administration of paracetamol was not an actual barrier. 
 
Eight workforce related perceived barriers were identified pre-intervention across the three 
elements of the intervention.  The use of insulin infusions and the pre-implementation 
concern that this might result in extra observations being required was considered to be a 
potential impact upon protocol adoption.  This was not unexpected as work overload and 
inadequate staffing have been seen to be a barrier in other studies (Hamilton et al., 2007).  
However, of interest, our post-implementation survey did not find any of the workforce 
concerns to be actual barriers to uptake of the protocols. 
 
None of the equipment perceived barriers identified pre-intervention were found to be actual 
barriers.  It is important to recognise that some perceived barriers that were identified in the 
pre-implementation workshop were successfully addressed prior to the trial commencement 
(i.e. lack of equipment) and indeed, this is the purpose of undertaking a barrier assessment.  It 
is likely this is why lack of equipment was not perceived as an actual barrier and encouraging 
that nurses were able to overcome this obstacle with no additional resources provided by the 
trial for this purpose. 
 
Our findings also demonstrated that a number of educational perceived barriers related to the 
implementation of the FeSS protocols directly involved medical staff, in particular the 
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continuous engagement of the doctors.  Future nurse-led and multidisciplinary studies in this 
area should aim to address issues surrounding the local engagement of medical staff.  This is 
an issue that has been identified in a number of previous studies investigating patient safety 
and quality initiatives (Gollop, Whitby, Buchanan, & Ketley, 2004) but can be difficult to 
achieve over the life of a trial such as ours (that ran for five years) due to frequent junior 
medical staff rotations.  
 
The importance of teamwork has been documented in the literature, particularly in stroke, 
(Baxter & Brumfitt, 2008; Indredavik, Bakke, Slordahl, Rokseth, & Haheim, 1999; Stroke 
Unit Trialists' Collaboration, 2007) and this was a key element of our trial, and addressed by 
inclusion of all relevant disciplines in the workshops.  This was also emphasised by the 
enablers that the staff identified, in particular, the importance of clinical site champions and 
supportive management.  Such findings are supported by the Cochrane review examining 
opinion leaders (Flodgren et al., 2007) which found that the use of opinion leaders can help 
evidence-based practice by promoting the evidence and bridging the evidence-practice gap.   
 
Our results show that not all perceived barriers eventuate as actual barriers.  There are a 
number of instances where this is reflected (e.g. potential increased workload, equipment 
supplies and paracetamol administration policies).  As previously mentioned, this could be a 
result of the barriers being successful addressed throughout the trial (i.e. purchasing of new 
equipment) or the willingness of the particular staff to actively address issues.  However, pre-
intervention identification of perceived ‘non-barriers’ may also reflect over-cautiousness by 
staff.  Examination of perceived and subsequent actual barriers to evidence implementation 
presents a number of challenges due to the paucity of high quality process evaluations (Drury 
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P et al., 2013) undertaken alongside these kinds of clinician practice change trials,(Grant, 
Treweek, Dreischulte, Foy, & Guthrie, 2013) and as such, our trial is significant because it 
presents a novel perspective.  This is an area where future study is warranted to better guide 
similar implementation studies and, in particular, to expunge pre-conceived attitudes to 




Perceived barriers to the implementation of new protocols may not always eventuate as actual 
barriers.  Nonetheless, identification of perceived barriers and enablers prior to an 
implementation strategy to enhance evidence-based clinical practice is especially valuable in 
a multidisciplinary context.  An opportunity for staff to identify, plan for and overcome 
barriers is a critical part of maximising clinical practice change.  In turn, this promotes 
clinician ownership over quality improvement initiatives and may accelerate successful 
implementation and translation of evidence into practice.  Ours is one of the few studies to 
compare the perceived barriers identified pre-implementation with actual barriers that were 
encountered.  This valuable process could assist with introduction of new interventions by 
helping to convince clinicians that not all barriers will eventuate. 
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Box: Linking Evidence to Action 
• Identification of barriers to practice change has been shown to improve evidence uptake  
• However, perceived barriers identified pre-implementation may not always turn out to be 
actual barriers 
• Education and engagement of the multi-disciplinary team supports successful implementation 
of relevant clinician behaviour change interventions 




















• Having clinical site champions for the trial 
• The support of neurologists in addition to the Stroke Unit 
Director 
• The support of senior staff 
 
Integration of the FeSS clinical treatment protocols into care: 
• Nurses ability to adapt local care plans 
• Being able to augment implementation with local strategies 
• Having staff exclusively allocated to the stroke unit 
17 
 







Nurses   
Registered Nurse 32 (29) 0 (0) 
Clinical Nurse Consultant 13 (12) 7 (70) 
Nurse Unit Manager 11 (10) 0 (0) 
Endorsed Enrolled Nurse 7 (6.3) 0 (0) 
Clinical Nurse Specialist 5 (4.5) 0 (0) 
Stroke Liaison Nurse 1 (0.9) 1 (10) 
Enrolled Nurse 1 (0.9) 0 (0) 
Clinical Nurse Educator 0 (0) 2 (20) 
Allied Health   
Speech Pathologist 14 (13) 0 (0) 
Physiotherapists 3 (2.7) 0 (0) 
Stroke Unit Coordinator 1 (0.9) 0 (0) 
Medical 15 (14) 0 (0) 
Other 2 (1.8) 0 (0) 
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Table 2: Perceived barriers identified pre-implementation and results of post-implementation survey (n=22) 
Perceived barriers identified pre-implementation Post-implementation survey results   















Policy barriers to the FeSS protocols 
 
     
Fever      
Inability to administer more than first dose of paracetamol without a written order 
 
0(0.0) 3(30.0) 3(30.0) 2(20.0) 2(20.0) 
Sugar      
Insulin infusions not previously allowed on stroke unit 4(40.0) 2(20.0) 1(10.0) 1(10.0) 2(20.0) 
Hyperglycaemic protocols could not be commenced without a written order 
 
2(20.0) 3(30.0) 1(10.0) 3(30.0) 0(0.0) 
Workforce barriers to the FeSS protocols 
 
Sugar      
Insufficient staff to safely look after more than one insulin infusion patient. 1(10.0) 0(0.0) 6(60.0) 1(10.0) 1(10.0) 
Endorsed Enrolled Nurses are not accredited to adjust insulin infusions or to test BGLs 1(10.0) 2(20.0) 3(30.0) 3(30.0) 1(10.0) 
Patients with insulin infusions requiring a nurse escort to leave the stroke unit 1(10.0) 0(0.0) 5(50.0) 2(20.0) 2(20.0) 
Not enough nurses to do hourly observations 
 
1(10.0) 1(10.0) 2(20.0) 4(40.0) 2(20.0) 
Swallow      
Insufficient speech pathology staff to train and assess nurses in performing swallow screens 
 
0(0.0) 1(10.0) 2(20.0) 3(30.0) 4(40.0) 
Generic      
High number of agency staff on the stroke unit 1(10.0) 1(10.0) 1(10.0) 5(50.0) 2(20.0) 
Finding a staff member to re-cannulate out of hours 1(10.0) 3(30.0) 1(10.0) 3(30.0) 2(20.0) 
Potential increase in nursing workload 
 
0(0.0) 1(10.0) 6(60.0) 2(20.0) 1(10.0) 
Equipment barriers to the FeSS protocols 
 
Fever      
Not enough thermometers on the stroke unit  0(0.0) 1(10.0) 2(20.0) 3(30.0) 4(40.0) 
Sugar      
Not enough syringe drivers on the stroke unit  1(10.0) 2(20.0) 1(0.0) 5(50.0) 1(10.0) 
Not enough blood glucose monitors on the stroke unit 0(0.0) 0(0.0) 3(20.0) 6(60.0) 1(10.0) 
Not enough fluid pumps on the stroke unit 
 
0(0.0) 0(0.0) 2(10.0) 7(70.0) 1(10.0) 
Education barriers to the FeSS protocols 
 
     
Swallow      
Time needed to undergo swallowing education 2(20.0) 2(20.0) 2(20.0) 3(30.0) 1(10.0) 
Medical staff reluctance to use the formal ASSIST tool 2(20.0) 6(60.0) 1(10.0) 0(0.0) 1(10.0) 
Reluctance of nursing staff to undertake screening role 0 (0.0) 1 (10.0) 2 (20.0) 5 (50.0) 2 (20.0) 
Generic      
Poor level of engagement with speech pathology staff (0.0) 0(0.0) 1(10.0) 1(10.0) 8(80.0) 
Poor level of engagement of medical staff 1(10.0) 4(40.0) 1(10.0) 4(40.0) 0(0.0) 
Doctors not aware of trial 1(10.0) 4(40.0) 2(20.0) 3(30.0) 0(0.0) 
Feasibility of educating night duty staff 1(10.0) 3(30.0) 2(20.0) 4(40.0) 0(0.0) 
* Bolded items are those considered to be actual barriers both pre- and post-implementation i.e. greater than 50% strongly agree or agree post-implementation   
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Table 3. Post-implementation additional questions (n=10)  






Don’t Know / Can’t 
remember 
n (%) 
Current use of FeSS protocols:       
Fever     9 (90) 1 (10) 0 (0) 
Sugar     7 (70) 3 (30) 0 (0) 
Swallowing     10 (100) 0 (0) 0 (0) 
        
Recommendation for use of FeSS protocols in 
the ED 
 
   9 (90) 1 (10) 0 (0) 













Don’t Know / Can’t 
remember 
n (%) 
Likelihood of recommending FeSS protocols 
to other ASUs 
 
6 (60) 3 (30) 0 (0) 0 (0) 1 (10) 0 (0) 













Don’t Know / Can’t 
remember 
n (%) 
Agreement that the FeSS protocols 
empowered nursing staff to approach the 
MDT team about patient management: 
      
Fever 3 (30) 3 (30) 4 (40) 0 (0) 0 (0) 0 (0) 
Sugar 3 (30) 4 (40) 2 (20) 1 (10) 0 (0) 0 (0) 
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